NCT05360069 Linear Stapler Versus Circular Stapler in Esophagojejunostomy
| NCT ID | NCT05360069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanchong Central Hospital |
| Condition | Postoperative Complications |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2020-01-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
With the development of stapler devices, various methods of esophagojejunostomy after laparoscopic total gastrectomy were evoluated. Which stapler is more advantageous has not been determined. At present, the most commonly used is linear stapler or Circular stapler in esophagojejunostomy. However, there is still a lack of reliable evidence for the selection of the two staplers. The purpose of this study is to explore the advantages of linear staper versus circular stapler in esophagojejunostomy for patients with gastric cancer who underwent total gastrectomy.
Eligibility Criteria
Inclusion Criteria: 1. Histologically confirmed adenocarcinoma of the stomach, T1-T4 stages. 2. Eastern Cooperative Oncology Group performance status of 0 or 1. 3. Adequate organ function. Exclusion Criteria: 1. Patients had distant metastasis. 2. oesophageal invasion of more than 3 cm. 3. Borrmann type 4 or large (more than 8 cm) type 3 carcinoma. 4. Previous chemotherapy or radiation therapy for any other malignancies.
Frequently Asked Questions
Who can join the NCT05360069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Postoperative Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05360069 currently recruiting?
Yes, NCT05360069 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nanchong Central Hospital to inquire about joining.
Where is the NCT05360069 trial being conducted?
This trial is being conducted at Nanchong, China.
Who is sponsoring the NCT05360069 clinical trial?
NCT05360069 is sponsored by Nanchong Central Hospital. The trial plans to enroll 100 participants.